VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March
16 March 2021 - 10:46PM
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company
committed to developing and commercializing a new generation of
medicines with the potential to go beyond the current standard of
care for anxiety, depression and other central nervous system (CNS)
disorders, today announced that Shawn Singh, VistaGen’s Chief
Executive Officer, will participate in the following investor
conferences in March:
Maxim
Group and M-Vest’s Inaugural Emerging Growth Virtual
Conference |
Dates: |
March 17th – 19th |
Format: |
Corporate Presentation & One-on-One Fireside Chat |
|
|
Date: |
Friday, March 19th at 1:00 p.m. ET |
Format: |
Fireside Chat with Jason McCarthy, Research Analyst |
Website: |
To attend the virtual conference, register here |
|
https://www.m-vest.com/events/2021-emerging-growth-virtual-conference |
Benzinga
Biotech Small Cap Conference |
Date: |
Thursday, March 25th at 10:05 a.m. ET |
Format: |
Corporate Presentation |
Website: |
To attend the virtual conference, register here |
|
https://events.benzinga.com/registration-page16068526119171607978331877 |
For more information regarding the conferences, please visit the
sponsor conference websites.
About VistaGenVistaGen Therapeutics is a
biopharmaceutical company committed to developing and
commercializing innovative medicines with the potential to go
beyond the current standard of care for anxiety, depression, and
other CNS disorders. Each of VistaGen's three drug candidates has a
differentiated potential mechanism of action, has been
well-tolerated in all clinical studies to date and has therapeutic
potential in multiple CNS markets. For more information, please
visit www.vistagen.com and connect with VistaGen on Twitter,
LinkedIn, and Facebook.
Company ContactMark A. McPartlandVistaGen
Therapeutics, Inc.Phone: +1 (650)
577-3600Email: IR@vistagen.com
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Apr 2024 to May 2024
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From May 2023 to May 2024